Immune checkpoint therapy + chemotherapy

1. Immune checkpoint therapy + chemotherapy activates immune response in silico.

   “immune checkpoint therapy combined with chemotherapy reprogrammed anti-tumor microenvironment enriched with FOLR2 + macrophages facilitated T-cell activations.”

   In silicoin triple-negative breast cancer

   Lipidic and senescent macrophages predict progression and response to combinatorial immunotherapy in triple-negative breast cancer

   bioRxiv (Cold Spring Harbor Laboratory)·Jun 28, 2024Preprint

More on Immune response